Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT

LABTLakewood-Amedex Biotherapeutics Inc. Common Stock US flag

NASDAQ Global Market

2.75

USD

-0.55

- -

1.29MMarket Cap

Income Statement (USD)

API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

Sales/Revenue/Turnover	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -
- Cost of Revenue	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -
Gross Profit	- -	- -	- -
+ Other Operating Income	- -	- -	- -
- Operating Expenses	9	4	4
+ Selling, General & Admin	3	2	3
+ Research & Development	6	2	1
+ Other Operating Expense	- -	- -	- -
Operating Income (Loss)	-9	-4	-4
- Non-Operating (Income) Loss	- -	1	- -
+ Interest Expense, Net	- -	- -	- -
+ Interest Expense	- -	- -	- -
- Interest Income	- -	- -	- -
+ Other Non-Op (Income) Loss	- -	1	- -
Pretax Income	-8	-5	-4
- Income Tax Expense (Benefit)	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -
Income (Loss) from Cont Ops	-8	-5	-4
- Net Extraordinary Losses (Gains)	- -	- -	- -
+ Discontinued Operations	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -
Income (Loss) Incl. MI	-8	-5	-4
- Minority Interest	- -	- -	- -
Net Income, GAAP	-8	-5	-4
- Preferred Dividends	- -	- -	- -
- Other Adjustments	- -	- -	- -
Net Income Avail to Common, GAAP	-8	-5	-4
EBIT	-9	-4	-4
EBITDA	-9	-4	-4
EBITDA Margin (%)	- -	- -	- -
EBITA	-9	-4	-4
Gross Margin (%)	- -	- -	- -
Operating Margin (%)	- -	- -	- -
Profit Margin (%)	- -	- -	- -
Sales per Employee	- -	- -	- -
Dividend per Share	- -	- -	- -
Depreciation Expense	- -	- -	- -
Basic Weighted Avg Shares	1	1	1
Basic EPS, GAAP	-11.84	-6.94	-2.76
Basic EPS from Cont Ops	-11.84	-6.94	-2.76
Diluted Weighted Avg Shares	1	1	1
Diluted EPS, GAAP	-11.84	-6.94	-2.76
Diluted EPS from Cont Ops	-11.84	-6.94	-2.76

Balance Sheet (USD)

API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

Total Current Assets	6	1	- -
+ Cash, Cash Equivalents & STI	6	1	- -
+ Cash & Cash Equivalents	3	1	- -
+ ST Investments	4	- -	- -
+ Accounts & Notes Receiv	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -
+ Inventories	- -	- -	- -
+ Raw Materials	- -	- -	- -
+ Work In Process	- -	- -	- -
+ Finished Goods	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -
+ Other Inventory	- -	- -	- -
+ Other ST Assets	- -	- -	- -
+ Misc ST Assets	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -
Total Noncurrent Assets	- -	- -	- -
+ Property, Plant & Equip, Net	- -	- -	- -
+ Property, Plant & Equip	- -	- -	- -
- Accumulated Depreciation	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -
+ LT Investments	- -	- -	- -
+ LT Receivables	- -	- -	- -
+ Other LT Assets	- -	- -	- -
+ Total Intangible Assets	- -	- -	- -
+ Goodwill	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -
+ Misc LT Assets	- -	- -	- -
Total Assets	7	1	- -
+ Payables & Accruals	2	- -	1
+ Accounts Payable	- -	- -	- -
+ Accrued Taxes	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -
+ Other Payables & Accruals	1	- -	- -
+ ST Debt	- -	- -	2
+ ST Borrowings	- -	- -	2
+ ST Finance Leases	- -	- -	- -
+ Other ST Liabilities	- -	- -	- -
+ Deferred Revenue	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -
+ Misc ST Liabilities	- -	- -	- -
Total Current Liabilities	2	1	2
+ LT Debt	- -	- -	- -
+ LT Borrowings	- -	- -	- -
+ LT Finance Leases	- -	- -	- -
+ Other LT Liabilities	- -	- -	- -
+ Accrued Liabilities	- -	- -	- -
+ Pension Liabilities	- -	- -	- -
+ Deferred Revenue	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -
+ Misc LT Liabilities	- -	- -	- -
Total Noncurrent Liabilities	- -	- -	- -
Total Liabilities	2	1	2
+ Preferred Equity and Hybrid Capital	- -	- -	- -
+ Share Capital & APIC	49	50	52
+ Common Stock	- -	- -	- -
+ Additional Paid in Capital	49	50	52
- Treasury Stock	- -	- -	- -
+ Retained Earnings	-45	-50	-53
+ Other Equity	- -	- -	- -
Equity Before Minority Interest	5	- -	-2
+ Minority/Non Controlling Interest	- -	- -	- -
Total Equity	5	- -	-2
Total Liabilities & Equity	7	1	- -
Shares Outstanding	1	1	1
Number of Employees	- -	- -	- -
Capital Leases - Total	- -	- -	- -
Net Debt	-2	-1	1
Net Debt to Equity	-51.11	-166.28	-64.32
Tangible Common Equity Ratio	66.08	37.98	-408.55
Current Ratio	3.14	1.55	0.13
Cash Conversion Cycle	- -	- -	- -

Cash Flow Statement (USD)

API ChatGPT

	2023 Y	2024 Y	2025 Y
As of date	12/31/2023	12/31/2024	12/31/2025

+ Net Income	-8	-5	-4
+ Depreciation & Amortization	- -	- -	- -
+ Non-Cash Items	1	- -	1
+ Stock-Based Compensation	1	- -	1
+ Deferred Income Taxes	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -
+ Other Non-Cash Adj	- -	- -	- -
+ Chg in Non-Cash Work Cap	1	-1	- -
+ (Inc) Dec in Accts Receiv	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	- -	- -
+ Inc (Dec) in Accts Payable	1	-1	1
+ Inc (Dec) in Other	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -
Cash from Operating Activities	-7	-6	-2
+ Change in Fixed & Intang	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	- -
+ Increase in Capital Stock	- -	- -	- -
+ Decrease in Capital Stock	- -	- -	- -
+ Net Change in LT Investment	-4	4	- -
+ Dec in LT Investment	7	8	- -
+ Inc in LT Investment	-11	-4	- -
+ Net Cash From Acq & Div	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -
+ Cash for JVs	- -	- -	- -
+ Other Investing Activities	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -
Cash from Investing Activities	-4	4	- -
+ Dividends Paid	- -	- -	- -
+ Net Cash From Debt	- -	- -	2
+ Cash From Debt	- -	- -	2
+ Repayments of Debt	- -	- -	- -
+ Other Financing Activities	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -
Cash from Financing Activities	- -	- -	2
Effect of Foreign Exchange Rates	- -	- -	- -
Net Changes in Cash	-11	-2	- -
EBITDA	-9	-4	-4
EBITDA Margin (%)	- -	- -	- -
Free Cash Flow	-7	-6	-2
Net Cash Paid for Acquisitions	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -
Free Cash Flow to Equity	- -	-6	- -
Free Cash Flow per Basic Share	-9.74	-8.18	-1.4
Price/Free Cash Flow	- -	- -	- -
Cash Flow to Net Income	0.82	1.18	0.51
Capital Expenditures	- -	- -	- -